Why ASLAN Pharmaceuticals (ASLN) Shares Are Down 40%
Why ASLAN Pharmaceuticals (ASLN) Shares Are Down 40%
ASLAN Pharmaceuticals Ltd (NASDAQ:ASLN) shares are trading lower by 38.7% to $0.68 during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.
ASLAN Pharmaceuticals Ltd (纳斯达克:ASLN)股票在周三交易中下跌38.7%，报0.68美元股，此前该公司宣布其在新加坡注册的唯一运营子公司已申请自愿清算。
The company says this decision was made following a thorough review of ASLAN SG's financial situation and strategic options. As a result, all employees of ASLAN SG and its subsidiary in the USA have been terminated.
该公司表示，经过对ASLAN SG的财务状况和战略选择进行全面审查后作出了这个决定。因此，ASLAN SG及其在美国的子公司的所有员工已被解雇。
The directors of ASLAN SG resolved that the subsidiary could not continue its business due to its liabilities. Luke Anthony Furler and Tan Kim Han of Quantuma (Singapore) Pte Limited were appointed as provisional liquidators to manage the winding up of ASLAN SG's affairs.
ASLAN SG的董事会决定，由于其负债，子公司无法继续经营。Quantuma (Singapore) Pte Limited的Luke Anthony Furler和Tan Kim Han被任命为临时清算人，管理ASLAN SG公务的清算。
Read Also: Fed Rate Cut Expectations Drop Mortgage Rates To 4-Month Lows: Surge In New Applications, Refinance Demand
阅读相关内容：联储降息预期使抵押贷款利率降至4个月低点：新申请和再融资需求激增
They will seek strategic alternatives for ASLAN's development programs and assets, settle obligations, and distribute remaining proceeds to creditors and shareholders according to Singaporean law.
他们将为ASLAN的发展计划和资产寻求战略替代方案，解决债务，并根据新加坡法律向债权人和股东分配剩余收益。
The parent company, ASLAN Pharmaceuticals, also resolved to apply for liquidation under Cayman law due to its liabilities. Previously, the company received a delisting notice from the Nasdaq Stock Market for failing to meet listing requirements and will move its trading to the over-the-counter market.
母公司ASLAN Pharmaceuticals也决定根据开曼法律申请清算，因为其负债。此前，该公司因未能符合上市要求而收到纳斯达克股票市场的退市通知，并将其交易转移到场外市场。
ASLN has a 52-week high of $25.44 and a 52-week low of $0.48.
ASLN的52周最高价为25.44美元，52周最低价为0.48美元。